Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse

Mark Levis, Farhad Ravandi, Eunice S. Wang, Maria R. Baer, Alexander Perl, Steven Coutre, Harry Erba, Robert K. Stuart, Michele Baccarani, Larry D. Cripe, Martin S. Tallman, Giovanna Meloni, Lucy A. Godley, Amelia A. Langston, Sergio Amadori, Ian D. Lewis, Arnon Nagler, Richard Stone, Karen Yee, Anjali AdvaniDan Douer, Wieslaw W. Jedrzejczak, Gunnar Juliusson, Mark R. Litzow, Stephen Petersdorf, Miguel Sanz, Hagop M. Kantarjian, Takashi Sato, Lothar Tremmel, Debra M. Bensen-Kennedy, Donald Small, B. Douglas Smith

Research output: Contribution to journalPublished meeting abstractpeer-review

Original languageEnglish
Pages (from-to)325-326
JournalBlood
Volume114
Issue number22
Publication statusPublished - 2009
Event51st Annual Meeting of the American-Society-of-Hematology - New Orleans, LA
Duration: 2009 Dec 52009 Dec 8

Subject classification (UKÄ)

  • Hematology

Cite this